Literature DB >> 24955193

Relationship of osteopontin and renal function with severity of coronary artery lesions.

Jian Chen1, Yingmin Lu1, Damin Huang1, Xiaohan Luo1, Yachen Zhang1.   

Abstract

AIM: To explore the relationship of plasma osteopontin (OPN) level and renal function with severity of coronary artery lesions.
METHODS: OPN level and renal function were detected and compared in 210 patients with coronary heart disease (CHD group) and 134 patients without coronary heart disease (control group) to analyze the relationship of osteopontin and renal function with severity of coronary artery lesions.
RESULTS: Plasma OPN and creatinine level were significantly higher in CHD group than those in control group (P<0.01), and estimated glomerular filtration rate (eGFR) was lower in CHD group than that in control group (P<0.01). The proportions of multi-vessel lesion and moderate to severe decreased renal function were higher in patients with high osteopontin than those in patients with low osteopontin (P<0.05), and the proportion of multi-vessel lesion was higher in patients with moderate to severe decreased renal function than that in normal renal function (P<0.05). Osteopontin and renal failure were the independent risk factors for coronary heart disease.
CONCLUSIONS: Plasma OPN level is associated with renal failure, both of which are correlated with the severity of coronary artery lesions.

Entities:  

Keywords:  Osteopontin; atherosclerosis; coronary heart disease; renal failure

Year:  2014        PMID: 24955193      PMCID: PMC4057872     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  10 in total

1.  Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease.

Authors:  Dimitris Tousoulis; Gerasimos Siasos; Konstantinos Maniatis; Evangelos Oikonomou; Stamatios Kioufis; Marina Zaromitidou; Thodoris Paraskevopoulos; Stavroula Michalea; Christina Kollia; Antigoni Miliou; Eleni Kokkou; Athanasios G Papavassiliou; Christodoulos Stefanadis
Journal:  Int J Cardiol       Date:  2012-05-27       Impact factor: 4.164

2.  Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease.

Authors:  Johan Lorenzen; Robert Krämer; Volker Kliem; Stefanie M Bode-Boeger; Hendrik Veldink; Hermann Haller; Danilo Fliser; Jan T Kielstein
Journal:  Eur J Clin Invest       Date:  2010-04       Impact factor: 4.686

3.  Osteopontin and carotid atherosclerosis in patients with essential hypertension.

Authors:  Mie Kurata; Takafumi Okura; Sanae Watanabe; Tomikazu Fukuoka; Jitsuo Higaki
Journal:  Clin Sci (Lond)       Date:  2006-11       Impact factor: 6.124

4.  Circulating osteopontin as a marker of early coronary vascular calcification in type two diabetes mellitus patients with known asymptomatic coronary artery disease.

Authors:  A E Berezin; A A Kremzer
Journal:  Atherosclerosis       Date:  2013-06-25       Impact factor: 5.162

Review 5.  Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease.

Authors:  Marta Scatena; Lucy Liaw; Cecilia M Giachelli
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-08-23       Impact factor: 8.311

6.  Prevalence of chronic kidney disease in the United States.

Authors:  Josef Coresh; Elizabeth Selvin; Lesley A Stevens; Jane Manzi; John W Kusek; Paul Eggers; Frederick Van Lente; Andrew S Levey
Journal:  JAMA       Date:  2007-11-07       Impact factor: 56.272

7.  Osteopontin transgenic mice fed a high-cholesterol diet develop early fatty-streak lesions.

Authors:  Kikuo Isoda; Yashuhiro Kamezawa; Makoto Ayaori; Masatoshi Kusuhara; Norihiro Tada; Fumitaka Ohsuzu
Journal:  Circulation       Date:  2003-02-11       Impact factor: 29.690

8.  Chronic kidney disease is associated with angiographic coronary artery disease.

Authors:  Michel Chonchol; Jeff Whittle; Angela Desbien; Michelle B Orner; Laura A Petersen; Nancy R Kressin
Journal:  Am J Nephrol       Date:  2007-11-29       Impact factor: 3.754

9.  Plasma osteopontin levels are associated with the presence and extent of coronary artery disease.

Authors:  Reiko Ohmori; Yukihiko Momiyama; Hiroaki Taniguchi; Rie Takahashi; Masatoshi Kusuhara; Haruo Nakamura; Fumitaka Ohsuzu
Journal:  Atherosclerosis       Date:  2003-10       Impact factor: 5.162

10.  Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus.

Authors:  Xiaoxiang Yan; Motoaki Sano; Lin Lu; Wei Wang; Qi Zhang; Ruiyan Zhang; Lingjie Wang; Qiujing Chen; Keiichi Fukuda; Weifeng Shen
Journal:  Cardiovasc Diabetol       Date:  2010-10-29       Impact factor: 9.951

  10 in total
  5 in total

1.  Effects on bone metabolism markers and arterial stiffness by switching to rivaroxaban from warfarin in patients with atrial fibrillation.

Authors:  Sayaka Namba; Minako Yamaoka-Tojo; Ryota Kakizaki; Teruyoshi Nemoto; Kazuhiro Fujiyoshi; Takehiro Hashikata; Lisa Kitasato; Takuya Hashimoto; Ryo Kameda; Kentaro Meguro; Takao Shimohama; Taiki Tojo; Junya Ako
Journal:  Heart Vessels       Date:  2017-02-23       Impact factor: 2.037

2.  A Retrospective Cohort Study of the Association between Serum Osteopontin Levels and Aortic Stiffness in Hypertensive Patients.

Authors:  Yuan-Chieh Chang; Jen-Pi Tsai; Ji-Hung Wang; Bang-Gee Hsu
Journal:  Int J Environ Res Public Health       Date:  2022-01-02       Impact factor: 3.390

3.  Association of serum osteopontin with first hospitalization and all-cause mortality after kidney transplantation.

Authors:  Hsiao-Hui Yang; Bang-Gee Hsu; Ching-Chun Ho; Ming-Che Lee
Journal:  Tzu Chi Med J       Date:  2021-04-01

4.  Plasma Osteopontin Levels and Adverse Cardiovascular Outcomes in the PEACE Trial.

Authors:  Ahmed D Abdalrhim; Tariq S Marroush; Erin E Austin; Bernard J Gersh; Nusret Solak; Syed A Rizvi; Kent R Bailey; Iftikhar J Kullo
Journal:  PLoS One       Date:  2016-06-10       Impact factor: 3.240

5.  Serum Osteopontin Level Is Positively Associated with Aortic Stiffness in Patients with Peritoneal Dialysis.

Authors:  Kai-Hsiang Chang; Chih-Hsien Wang; Bang-Gee Hsu; Jen-Pi Tsai
Journal:  Life (Basel)       Date:  2022-03-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.